Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
  1. 4 Grant or award Director acquired 11,215 shares (grant or award)
  2. 4 Grant or award Director acquired 11,215 shares (grant or award)
  3. 4 Grant or award Director acquired 11,215 shares (grant or award)
  4. 4 Grant or award EVP, Pres., Novocure Oncology acquired 179,426 shares (grant or award)
  5. 4 Open-market sale Director sold 999 shares at $17.28 ($17,259)
  6. 4 Open-market sale Director sold 999 shares at $17.31 ($17,297)
  7. 4 Open-market sale Director sold 999 shares at $17.19 ($17,176)
  8. 4 Open-market sale Director sold 999 shares at $17.32 ($17,299)
  9. 4 Open-market sale Director sold 999 shares at $17.26 ($17,247)
  10. 4 Open-market sale Director sold 999 shares at $17.29 ($17,269)
  11. 4 Open-market sale Director sold 999 shares at $17.35 ($17,329)
  12. 4 Open-market sale Director sold 999 shares at $17.30 ($17,280)
  13. 4 Planned sale EVP, Pres., Novocure Oncology sold 30,196 shares at an average $17.50 ($528,413)
  14. 4 Open-market sale Chief Operating Officer sold 592 shares at $17.91 ($10,604)
  15. 4 Grant or award Chief Financial Officer acquired 54,975 shares (grant or award)
  16. 4 Grant or award Chief Medical Officer acquired 54,975 shares (grant or award)
  17. 4 Grant or award General Counsel acquired 54,975 shares (grant or award)
  18. 4 Grant or award Chief Human Resources Officer acquired 54,975 shares (grant or award)
  19. 4 Grant or award Chief Innovation Officer acquired 54,975 shares (grant or award)
  20. 4 Grant or award EVP, Pres., Novocure Oncology acquired 54,975 shares (grant or award)

Page 4 of 39 · 780 filings